March 18, 2025 - 04:51

The worldwide tech-leading Dutch firm, cosine, is making a significant impact in space exploration. The company is playing a key role in the European Space Agency’s (ESA) Hera mission by providing a powerful imaging system that successfully captured historic images of Mars and its moon, Deimos, during a recent flyby. This innovative technology is designed to enhance our understanding of celestial bodies and their formations.
The Hera mission aims to study the binary asteroid system Didymos and its moonlet Dimorphos, but the successful imaging of Mars and Deimos showcases cosine's capabilities beyond its primary objectives. The advanced imaging technology utilized during the flyby allows scientists to gather crucial data, which could lead to breakthroughs in planetary science.
As space missions become increasingly complex, the contributions from companies like cosine highlight the importance of collaboration between private enterprises and governmental space agencies. Their work not only advances scientific knowledge but also inspires future generations to explore the cosmos.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...